Stock comparison
BRUKER CORP is 1.7x more valuable than 10x Genomics, Inc. by market capitalization ($9.22 B vs $5.50 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BRKR is larger
BRUKER CORP is 1.7x more valuable than 10x Genomics, Inc. by market capitalization ($9.22 B vs $5.50 B).
Market value leader
BRKR
BRUKER CORP is 1.7x more valuable than 10x Genomics, Inc. by market capitalization ($9.22 B vs $5.50 B).
Revenue leader
BRKR
TXG: $642.82M vs BRKR: $3.44B.
Profit leader
BRKR
TXG: -$43.50M vs BRKR: -$8.30M.
Margin leader
BRKR
TXG: -6.8% vs BRKR: -0.2% net margin.
| Metric | TXG | BRKR |
|---|---|---|
| Market cap | $5.50 B | $9.22 B |
| US-listed rank | #1345 | #1006 |
| Revenue (latest FY) | $642.82M | $3.44B |
| Net income (latest FY) | -$43.50M | -$8.30M |
| Net margin | -6.8% | -0.2% |
| P/E (trailing FY) | - | - |
| SEC filings | 652 | 1,361 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BRUKER CORP is 1.7x more valuable than 10x Genomics, Inc. by market capitalization ($9.22 B vs $5.50 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while BRUKER CORP reported $3.44B.
Full pages: 10x Genomics, Inc. and BRUKER CORP, or browse the full rankings.